Par Pharmaceutical has bought rights to a generic drug for gastroesophageal reflux disease from Handa Pharmaceuticals, Par said.
Sam's Club will host a supplier fair this week in Bentonville, Ark., through the company's supplier diversity program.
Watson Pharmaceuticals announced the launch of an authorized generic version of a drug used to lower blood glucose in patients with Type 2 diabetes.
Anglo-Swedish drug maker AstraZeneca will buy a San Diego-based biotech company for $1.26 billion, the two said Monday.
Pfizer is selling its nutrition business to Nestle for $11.85 billion, Pfizer said Monday.
Suave Professionals has launched a new contest on its Spanish-language Facebook page with help from the brand's Keratin Infusion line.
J. M. Smucker has promoted one of its corporate officers.
Drug Store News recently spoke with Greg Bradley, president and CEO of Advantage Consumer Healthcare (Booth #368) about the OTC healthcare space.
Merck is testing two means of treating patients with chronic hepatitis C for anemia, a common side effect of certain treatments for the viral infection, the drug maker said.
Drug maker Genzyme plans to present data from trial programs of two multiple sclerosis drugs at the American Academy of Neurology's annual meeting in New Orleans, which starts this Saturday and lasts until next Saturday.